Cytokine induced killer cell(Chuan An Biotechnology)

N/A

Report date: 2023/03/15 10:34:34

Base Information

Drug NameCytokine induced killer cell(Chuan An Biotechnology)
Drug Alias NameCABIO-CIK-1701
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Cytokine-induced killer cell
Mechanisms of ActionImmunostimulantsCytokine-induced killer cells stimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesChuan An Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesChuan An Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A